MedMira Inc.
MMIRF · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -41.7% | -4.6% | -54.6% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -297.2% | 54.9% | 69.4% | 31.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -939.4% | -517.3% | -364.7% | -112.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,881.2% | -806.2% | -618.6% | -192.4% |
| EPS Diluted | -0.005 | -0.005 | -0.004 | -0.003 |
| % Growth | 2.1% | -26.3% | -40.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |